Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here is fraudulent Ponzi Scheme operator Beplate from 2013 bullshitting everyone how wonderful the elusive fictional magic bandage was back then. And now, over a decade later, we still, starting with the FDA, cannot ever see this fantastical magic bandage.
Douglas Beplate from 2013
He must be laughing and smiling at the thought of how naive and gullible his marks for the con are.
Last time angels was in his glory, filming commenced out of the blue.
Should they ignore your hand in their purse?
Set chrism on ignore or lose your wallet.
Is ignoring common sense wise when victimized by Ponzi scheme operators?
Ponzi scheme operators depend on ignorance and gullibility.
Only Ponzi Scheme operators find defrauding shareholders acceptable business.
Fact...The SEC already determined UHP fraudulent :
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
It's been over a decade... absurd crock of bullshit!!!!!
Why no FDA submission for hidden bandage after well over a decade?
Let's discuss your motivation instead.
Nice imagination. Happy New Year by the way surf. Best wishes for a healthy, prosperous, and joyful year for you and your buddy angels.
Where were the sales for these supposed wash trades?
Someone scooped up a lot of .0002's today...like all of them that were available at that price.
That's your prerogative. However, there is no functional company supporting the share price. Share prices for empty shells should be in the extremely low trips. You might someday realize the hard way this share price is beyond exorbitant and nothing more than the product of fraud and manipulation.
The only good reason I can think of is his hands are being tied by a major US network that wants to announce and handle the PR for the show (and that is usually how it works anyway), It makes no sense from a business standpoint to drag this out. With the strike ongoing, it is best to air the show now while the competitive shows are handicapped by the strike. There may be other good reasons for the silence, but I cannot think of them. So I expect we should hear very soon.
Looking back, it seemed like nothing was happening, then suddenly final rehearsal photos hit social media and it was done taping within days. Another reason I am not pessimistic, is this wasn't filmed for nothing. Especially so with the caliber of individuals involved. There are a lot of celebrities involved and expecting big things to come from their involvement. Mr. Blagman has more riding on this to happen than just supporting shareholders.
Broker/CEO Thom knows how to manipulate empty shells. wtf do you think makes this so dangerous for those who are not insiders to this scam like you dudes? I wish I knew the need to praise a Ponzi Scheme like this blatantly taking advantage of the gullible and naive, trying to fish out suckers to buy in after you guys as you sell. Wash, rinse, repeat with no functional company whatsoever.
"BUY BUY"
They certainly aren't trying to manipulate share price. In that sense, they are doing shareholders no favors.
Here's to pump and dumpers continuing to pimp those foolish enough to be long term shareholders of this POS scam. After well over a decade of bait and switch PR's and utter bullshit hype, who would believe there is anything happening here except manipulation?
Angels, I see you're in rare form lately.
Sleezy thieving dark doesn't want the truth out.
SEC says United_Health_Products is full of shit
1.This is an accounting fraud case arising from schemes by UHP's then-Chief
Executive Officer, Beplate, and then-Chief Operating Officer, Schiliro, to fraudulently report
inflated revenues and receivables in the Forms 10-Q and 10-K for 2017 and 2018 UHP filed with
the Commission.
2. UHP is a manufacturer of hemostatic gauze for the healthcare and wound care
sectors. During 2017, UHP recorded two fraudulent sales that materially overstated its reported
revenue and accounts receivable balances in its publicly-filed financial statements. The first
fraudulent transaction involved a purported March 31, 2017 sale of product to a customer based
on Beplate's and Schiliro's procurement in early May 2017 of a sham, back-dated purchase
order. The customer formally cancelled the order the following day, UHP never shipped the
product to the customer, and no payment was sought or received from the customer.
Nevertheless, UHP reported the transaction as first quarter 2017 revenue from the "sale" and the
full amount in its accounts receivable balance in its Forms I0-Q for the first three quarters of
2017.
3. The second fraudulent transaction involved Beplate and Schiliro orchestrating the
recognition of a purported December 20, 2017 sale of product to UHP's largest customer that
was delivered in February 2018. However, the customer never agreed to purchase the product.
Despite the fact that there was no legitimate sale, UHP reported it as revenue and included the
full amount in its accounts receivable balance in its 2017 Form 10-K annual financial statements,
and continued to report it as part of its total accounts receivable balances in its 2018 Forms I0-Q.
4. To conceal their fraud and justify the revenues and receivables being recognized,
Beplate and Schiliro repeatedly gave UHP's auditors false explanations about the purported sales
2
Case 1:22-cv-03612 Document 1 Filed 06/08/22 Page 2 of 44 PageID: 2
and concealed the true facts and circumstances surrounding them. They also directly or
indirectly provided the auditors with false documents, including bogus sales invoices and
incorrect shipping documentation and falsified accounting records, and Beplate lied to UHP's
auditors in quarterly and annual management representation letters.
5. As a result of Beplate's and Schiliro's fraud, UHP reported materially overstated
total revenues and accounts receivable balances in its Forms 10-Q and 10-K for 2017 and 2018,
each of which Beplate signed and falsely certified.
VIOLATIONS
6. By virtue of the foregoing conduct and the conduct alleged further herein,
Defendant UHP violated Section l 7(a) of the Securities Act of 1933 ("Securities Act) [ 15
U.S.C. $ 77q(a)]; Sections 10(b), 13(a), 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange
Act of 1934 ("Exchange Act") [ 15 U.S.C. $$ 78j(b), 78m(a), 78m(b)2)A) and 78m(b)(2)(B)]
and Rules 10b-5, 12b-20, 13a-1, and 13a-13 [17 CF.R. $$ 240.10b-5, 240.12b-20, 240.13a-1 and
240. 13a-13] thereunder;
7. Defendant Beplate violated Section 17(a) of the Securities Act [15 U.S.C.$
77q(a)]; Sections l0(b), 13(b)(5) and 16(a) of the Exchange Act [15 U.S.C. §§ 78j(b), 78m(b)(5)
and 78p(a)] and Rules 10b-5, 13a-14, 13b2-1, 13b2-2 and 16a-3 [17 C.F.R. $$ 240.10b-5,
240.13a-14, 240.13b2-1, 240.13b2-2 and 240.16a-3] thereunder; Section 304(a) of the SarbanesOxley Act of2002 [15 U.S.C. § 7243(a)]; and aided and abetted UHP's violations of Sections
13(a), 13(b)(2)(A) and 13(b)(2)(B) of the Exchange Act [15 U.S.C. $$ 78m(a), 78m(b)(2)(A) and
78m(b)(2)(B)] and Rules 12b-20, 13a-1, and 13a-13 [17 CF.R. $$ 240.12b-20, 240.13a-1 and
240. 13a-13] thereunder; and
8. Defendant Schiliro violated Section l 7(a) of the Securities Act [15 U.S.C. §
3
Case 1:22-cv-03612 Document 1 Filed 06/08/22 Page 3 of 44 PageID: 3
77q(a)]; Sections 10(b) and 13(b)(5) of the Exchange Act [15 U.S.C. $$ 78jb) and 78m(b)(5)]
and Rules 10b-5(a), 10b-5(c), 13b2-1 and 13b2-2 [17 CF.R. $$ 240.10b-5(a), 240.10b-5(c),
240. 13b2-1 and 240. 13b2-2] thereunder; and aided and abetted UHP's violations of Sections
10(b), 13(a), 13(b)2)A) and 13(b)(2)(B) of the Exchange Act [15 U.S.C. $$ 78jb), 78m(a),
78m(b)(2)(A) and 78m(b)(2)(B)] and Rules 10b-5(b), 12b-20, 13a-1 and 13a-13 [17 C.F.R. $$
240.10b-5(b), 240.12b-20, 240.13a-1 and 240.13a-13] thereunder.
9. Unless Defendants are restrained and enjoined, they will continue to engage in the
acts, practices, transactions, and courses of business set forth in this Complaint or in acts,
practices, transactions, and courses of business of similar type and object.
NATURE OF THE PROCEEDINGS AND RELIEF SOUGHT
10. The Commission brings this action pursuant to the authority conferred upon it by
Exchange Act Section 2l(d) [15 U.S.C. $ 78ud)] and Sections 20(b), 20(d) and 20(e) of the
Securities Act [15 U.S.C. §§ 77t(b), 77t(d) and 77t(e)].
11. The Commission seeks a final judgment: (a) restraining and permanently
enjoining Defendants from violating the federal securities laws and rules this Complaint alleges
they have violated; (b) ordering Defendants to pay civil money penalties pursuant to Section
20(d) of the Securities Act [15 U.S.C. § 77t(d)] and Section 2l(d)(3) of the Exchange Act [15
U.S.C. $ 78u(d)(3)]; (c) permanently prohibiting Beplate and Schiliro from serving as an officer
or director of any company that has a class of securities registered under Exchange Act Section
12 [ 15 U.S.C. § 781], or that is required to file reports under Exchange Act Section 15(d)
[15 U.S.C. § 78o(d)], pursuant to Exchange Act Section 21(d)2) [15 U.S.C. $ 78u(@)2)] and
Securities Act Section 20(e) [15 U.S.C. U.S.C. $ 77t(e)]; (d) ordering that Beplate reimburse
UHP for all bonuses, incentive-based and equity-based compensation, and/or profits realized
4
Case 1:22-cv-03612 Document 1 Filed 06/08/22 Page 4 of 44 PageID: 4
from his sale of UHP stock pursuant to Section 304 of the Sarbanes-Oxley Act of2002 [15
U.S.C. $ 7243(a)]; and (c) ordering any other and further relief the Court may deem just and
proper.
We'll see who the dumb asses are and who the intelligent posters are as this unfolds.
There are some intelligent posters here besides either dumb asses or pumpers.
Networks usually do the announcing. It isn't already being seen on Brian Gartland entertainment for no reason. Would you rather step on the toes of the network it will be debuting at? It's a done deal. Relax. You'll see a publicity blitz soon. And bear in mind this is airing in many countries.
I'm the opposite. I'm very impressed. Mr. Blagman has exceeded my expectations. I'd much rather have everything handled to maximize the long term success. The people criticizing this will soon be made asses out of.
CEO Jason did an outstanding job of bringing Mr. Blagman on board!!!!!!
Angels is the poster, long history of misinformation.
Let's not forget, the show itself will give the investment a lot of publicity many products cannot garner.
Utter bullshit!!! There has never been any clinical study whatsoever.
I still believe in the hemostyp gauze device II technology! Bottom line does it work in a surgical setting? The real value is in the foam and gel potential although this would require another clinical study IMO.
If there is no product, the application is kind of pointless; isn't it? Outside of a few internet con artists who make claims, no one independent, including the FDA, has ever seen this magic bandage.
Concur. It stretches the imagination as to why competent people can not master the process of getting an application
accomplished and into the FDA. What really is the problem. Identify the problem and fix it.
Hoping to keep shares cheap prior to his announcement? It's coming in under a week. We'll see who eats crow. Judging from the bullshit, I'm assuming you get plenty of helpings.
NOTHING TO REPORT?
1. File the PMA application.j
2. Communicate.
3. Or get out of the way and find someone who can. Your incompetence is showing.